The Major Long-Term Risk Facing Altria Stock in 2026

Altria's diversification beyond cigarettes has largely failed; its On! oral nicotine pouch has had some success but faces stiff competition from Philip Morris's dominant Zyn brand. This competitive pressure limits Altria's growth prospects in nicotine alternatives and reduces the near-term upside from its product diversification strategy.

Analysis

Altria's diversification beyond cigarettes has largely failed; its On! oral nicotine pouch has had some success but faces stiff competition from Philip Morris's dominant Zyn brand. This competitive pressure limits Altria's growth prospects in nicotine alternatives and reduces the near-term upside from its product diversification strategy.